Skip to main content

‘Imitinef Mercilet’ curing Blood Cancer!! Hoax


I just received a mail in the mail Which is is as follows:
 Dear All,

Please send to your colleagues and friends as many you can. Do not delete without sending to anybody.
I have forwarded it to the maximum I can.
Let it reach the 110 crores Indians and the remaining if any.
‘Imitinef Mercilet’ is a medicine which cures blood cancer. Its available free of cost at “Adyar Cancer Institute in Chennai”. Create Awareness. It might help someone.  
Forward to as many as u can, kindness costs  nothing.
Just revealing a fact about this.

Please don’t forward this without being ignorant as this seems to be a hoax. This seemed too good to be true so I googled a little and found out the following:

According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.

Popular posts from this blog

Visualizing large scale Uber Movement Data

Last month one of my acquaintances in LinkedIn pointed me to a very interesting dataset. Uber's Movement Dataset. It was fascinating to explore their awesome GUI and to play with the data. However, their UI for exploring the dataset leaves much more to be desired, especially the fact that we always have to specify source and destination to get relevant data and can't play with the whole dataset. Another limitation also was, the dataset doesn't include any time component. Which immediately threw out a lot of things I wanted to explore. When I started looking out if there is another publicly available dataset, I found one at Kaggle. And then quite a few more at Kaggle. But none of them seemed official, and then I found one released by NYC - TLC which looked pretty official and I was hooked.
To explore the data I wanted to try out OmniSci. I recently saw a video of a talk at jupytercon by Randy Zwitch where he goes through a demo of exploring an NYC Cab dataset using OmniSci. A…

HackRice 7.5: How "uFilter" was born

I have a thing for Hackathon. I am a procrastinator. A lazy and procrastinator graduate student, not a nice combination to have. But still when I see hundreds of sharp minds in a room scrabbling over idea, hungry to build and prototype their idea. Bring it to life, it finally pushes me to activity, makes me productive.  That is why I love Hackathon, that is why I love HackRice, our resident Hackathon of Rice University.

TL;DR: if you just want to try the extension, chrome version is here and Firefox version is here.
I have been participating at HackRice since 2014, when I think for the first time it was open for non-rice students, and have been participating ever since. What a roller coaster ride it has been, but that is a story for another day. HackRice 7.5 being the last one I will be able to attend at Rice, it was somewhat special and emotional for me.
HackRice 7.5 was a tad different form the other iterations. For starters it was the first time it was being held in Spring semester…

FirefoxOS, A keyboard and prediction: Story of my first contribution

Returning to my cubical holding a hot cup of coffee and with a head loaded with frustration and panic over a system codebase that I managed to break with no sufficient time to fix it before the next morning. 

This was at IBM, New York where I was interning and working on the TJ Watson project. I returned back to my desk, turned on my dual monitors, started reading some blogs and engaging on Mozilla IRC (a new found and pretty short lived hobby). Just a few days before that, FirefoxOS was launched in India in the form of an Intex phone with a $35 price tag. It was making waves all around, because of its hefty price and poor performance . The OS struggle was showing up in the super low cost hardware. I was personally furious about some of the shortcomings, primarily the keyboard which at that time didn’t support prediction in any language other than English and also did not learn new words. Coincidentally, I came upon Dietrich Ayala in the FirefoxOS IRC channel, who at that time was a P…